Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;147(9):1031-9.
doi: 10.1001/archdermatol.2011.119. Epub 2011 May 16.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

Nehal N Mehta  1 , YiDing Yu, Babak Saboury, Negar Foroughi, Parasuram Krishnamoorthy, Anna Raper, Amanda Baer, Jules Antigua, Abby S Van Voorhees, Drew A Torigian, Abass Alavi, Joel M Gelfand
Affiliations

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

Nehal N Mehta et al. Arch Dermatol. 2011 Sep.

Abstract

Objective: To evaluate the feasibility of using [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) to detect and quantify systemic inflammation in patients with psoriasis.

Design: Case series with a nested case-control study.

Setting: Referral dermatology and preventive cardiology practices.

Participants: Six patients with psoriasis affecting more than 10% of their body surface area and 4 controls age and sex matched to 4 of the patients with psoriasis for a nested case-control study.

Main outcome measures: The FDG uptake in the liver, musculoskeletal structures, and aorta measured by mean standardized uptake value, a measure of FDG tracer uptake by macrophages and other inflammatory cells.

Results: FDG-PET/CT identified numerous foci of inflammation in 6 patients with psoriasis within the skin, liver, joints, tendons, and aorta. Inflammation in the joints was observed in a patient with psoriatic arthritis as well as in 1 patient with no history of joint disease or joint symptoms. In a nested case-control study, FDG-PET/CT imaging demonstrated increased vascular inflammation in multiple segments of the aorta compared with controls. These findings persisted after adjustment for traditional cardiovascular risk factors in multivariate analysis (mean β = 0.33; P < .001). Patients with psoriasis further demonstrated increased hepatic inflammation after adjusting for cardiovascular risk factors (β = 0.18; P < .001), but the association was no longer significant when adjusted for alcohol intake (β = -0.25; P = .07).

Conclusion: FDG-PET/CT is a sensitive tool for identifying inflammation and can be used to identify clinically observed inflammation in the skin and subclinical inflammation in the blood vessels, joints, and liver of patients with psoriasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. FDG-PET/CT imaging of skin correlates with observed skin inflammation
(a) Photograph of patient with psoriasis showing extensive multifocal plaques. (b) Corresponding PET image from FDG-PET/CT study in same patient demonstrates skin inflammation in similar distribution.
Figure 2
Figure 2. FDG-PET/CT imaging Shows Multifocal Inflammation in Patient with Psoriasis Compared to Control
PET image from FDG-PET/CT study in patient with psoriasis is shown at left. FDG-PET image from control patient is shown at right for comparison (no abnormal FDG uptake). (A) FDG uptake in right knee joint (SUV 3.0) and distal right quadriceps tendon, left trochanteric bursa, and left ankle in asymptomatic psoriasis patient. (B) Moderate diffusely increased FDG uptake throughout liver (SUV 1.64) consistent with increased hepatic inflammation. (C) Diffuse FDG uptake in aortic wall (SUV 1.29–1.72) and in femoral arterial tree, consistent with vascular inflammation. (D) Focal areas of FDG uptake in skin consistent with inflammation in thick plaques in lower extremities.
Figure 2
Figure 2. FDG-PET/CT imaging Shows Multifocal Inflammation in Patient with Psoriasis Compared to Control
PET image from FDG-PET/CT study in patient with psoriasis is shown at left. FDG-PET image from control patient is shown at right for comparison (no abnormal FDG uptake). (A) FDG uptake in right knee joint (SUV 3.0) and distal right quadriceps tendon, left trochanteric bursa, and left ankle in asymptomatic psoriasis patient. (B) Moderate diffusely increased FDG uptake throughout liver (SUV 1.64) consistent with increased hepatic inflammation. (C) Diffuse FDG uptake in aortic wall (SUV 1.29–1.72) and in femoral arterial tree, consistent with vascular inflammation. (D) Focal areas of FDG uptake in skin consistent with inflammation in thick plaques in lower extremities.
Figure 2
Figure 2. FDG-PET/CT imaging Shows Multifocal Inflammation in Patient with Psoriasis Compared to Control
PET image from FDG-PET/CT study in patient with psoriasis is shown at left. FDG-PET image from control patient is shown at right for comparison (no abnormal FDG uptake). (A) FDG uptake in right knee joint (SUV 3.0) and distal right quadriceps tendon, left trochanteric bursa, and left ankle in asymptomatic psoriasis patient. (B) Moderate diffusely increased FDG uptake throughout liver (SUV 1.64) consistent with increased hepatic inflammation. (C) Diffuse FDG uptake in aortic wall (SUV 1.29–1.72) and in femoral arterial tree, consistent with vascular inflammation. (D) Focal areas of FDG uptake in skin consistent with inflammation in thick plaques in lower extremities.
Figure 2
Figure 2. FDG-PET/CT imaging Shows Multifocal Inflammation in Patient with Psoriasis Compared to Control
PET image from FDG-PET/CT study in patient with psoriasis is shown at left. FDG-PET image from control patient is shown at right for comparison (no abnormal FDG uptake). (A) FDG uptake in right knee joint (SUV 3.0) and distal right quadriceps tendon, left trochanteric bursa, and left ankle in asymptomatic psoriasis patient. (B) Moderate diffusely increased FDG uptake throughout liver (SUV 1.64) consistent with increased hepatic inflammation. (C) Diffuse FDG uptake in aortic wall (SUV 1.29–1.72) and in femoral arterial tree, consistent with vascular inflammation. (D) Focal areas of FDG uptake in skin consistent with inflammation in thick plaques in lower extremities.
See this image and copyright information in PMC

References

    1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005 Dec;141(12):1537–1541. - PubMed
    1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009 Feb;60(2):218–224. - PMC - PubMed
    1. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005 Oct;53(4):573. - PubMed
    1. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009 Apr;145(4):379–382. - PMC - PubMed
    1. Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol. 2008 Sep 6; - PubMed

Publication types

Substances